Company Divas Pharm Srl with Fiscal Code 24586021
recorded a turnover of 2024 of
476.048,
with a net profit of
45.197
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Divas Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
67.984
59.298
82.671
131.442
164.348
209.782
256.304
316.348
414.449
476.048
Total Income - EUR
67.985
59.298
83.467
131.463
164.349
209.783
256.377
316.430
414.471
476.187
Total Expenses - EUR
66.613
61.522
80.319
111.389
146.290
184.535
224.952
292.071
362.368
421.743
Gross Profit/Loss - EUR
1.372
-2.223
3.148
20.075
18.059
25.248
31.425
24.359
52.102
54.445
Net Profit/Loss - EUR
658
-2.816
2.032
18.760
16.416
23.150
29.165
21.513
48.036
45.197
Employees
2
2
1
2
2
2
2
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.5%, from 414.449 euro in the year 2023, to 476.048 euro in 2024.
The Net Profit decreased by -2.571 euro, from 48.036 euro in 2023, to 45.197 in the last year.
Check the financial reports for the company - Divas Pharm Srl
Financial Rating - DIVAS PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Divas Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Divas Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Divas Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Divas Pharm Srl - CUI 24586021
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
11.762
10.549
11.317
10.742
10.133
9.503
8.899
42.764
31.830
21.815
Current Assets
28.279
14.938
33.414
52.700
55.271
97.521
125.162
104.044
140.258
195.156
Inventories
9.838
7.200
15.777
25.621
33.181
48.644
46.086
50.108
66.790
79.685
Receivables
5.840
1.734
10.732
12.437
19.209
32.928
37.169
44.746
54.705
36.734
Cash
12.601
6.004
6.905
14.642
2.881
15.949
41.908
9.189
18.762
78.737
Shareholders Funds
15.264
3.385
7.897
23.502
21.066
27.711
44.894
54.136
63.933
95.877
Social Capital
90
89
88
172
169
165
162
162
162
161
Debts
24.776
22.102
36.834
39.940
44.339
79.312
89.168
92.672
108.155
121.093
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
195.156 euro in 2024 which includes Inventories of
79.685 euro, Receivables of
36.734 euro and cash availability of
78.737 euro.
The company's Equity was valued at
95.877 euro, while total Liabilities amounted to
121.093 euro.
Equity increased by 32.302 euro, from 63.933 euro in 2023, to 95.877 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Divas Pharm Srl